KIORA PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
KIORA PHARMACEUTICALS, INC. (KPRX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest · last filed 2017-02-23
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2016-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2016-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2016-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2016 was $0.00.
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2015 was -$32.97K, a 1845.21% decline from fiscal 2014.
- KIORA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2014 was $1.89K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | -$32.97K 10-K · filed 2017-02-23 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | -$32.97K 10-Q · filed 2016-11-01 | $90.50K derived: sum of 4 quarters · filed 2016-11-01 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | -$32.97K 10-Q · filed 2016-08-10 | $90.50K derived: sum of 3 quarters · filed 2016-08-10 | $3.73K derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | $32.97K 10-Q · filed 2016-05-13 | -$32.97K 10-Q · filed 2015-05-18 | $90.50K derived: sum of 2 quarters · filed 2016-05-13 | $3.73K derived: sum of 3 quarters · filed 2016-05-13 | $28.04K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $57.53K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$29.24K derived: sum of 2 quarters · filed 2016-03-30 | -$4.93K derived: sum of 3 quarters · filed 2016-03-30 | $1.89K 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$86.77K 10-Q · filed 2015-11-12 | -$62.46K derived: sum of 2 quarters · filed 2015-11-12 | -$55.64K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $24.31K 10-Q · filed 2015-08-12 | $31.13K 10-Q · filed 2015-08-12 | |||
| 2014-03-31 | $6.82K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |